Pence rules out Medicaid expansion in current form
Gov. Mike Pence said Wednesday that he has ruled out expanding Medicaid under the federal health care law unless Indiana gets approval to use state health savings accounts for the expansion.
Health Care & Life Sciences
Articles
Lilly aims to submit five new drugs for approval
With Eli Lilly and Co. set to see patents expire on its best-selling drug at year’s end, it is in the company’s interest to say its pipeline is about to produce new drugs. But the Indianapolis drugmaker may be in a position to submit five new drugs for regulatory approval this year.
Community taps Walgreens for health reform help
In the era of health care reform, hospitals will face two new challenges: They will need to run higher-volume, lower-margin businesses, and they’ll be on the hook financially for what patients do even when they’re not receiving health care. Community Health Network’s new partnership with Walgreens’ Take Care Clinics is designed to help address both issues.
Health care startups hungry for funds
Frustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create a dedicated funding stream that could total $30 million a year.
Law firm adds pharmacy practice
Hall Render Killian Heath & Lyman will draw on existing expertise within the firm to create the 10-member group.
Zimmer’s earnings slip, but beat expectations
Fourth-quarter profit fell 2 percent at Zimmer Holdings Inc. due to large accounting charges, but still beat the estimates of Wall Street analysts.
Cold medicines could face tighter limits in Indiana
An Indiana Senate committee has backed tougher limits on quantities consumers may buy of cold medications that can be used to make methamphetamine.
Life sciences consultancy plans to expand, add 38 jobs
Indianapolis-based Pearl Pathways, founded by two former Eli Lilly employees, plans to move into new space in March and add the jobs by 2016.
Lilly’s profit drops 4 percent, but beats analysts’ estimates
Price increases and sales gains helped Eli Lilly and Co. offset declining revenue from its former blockbuster Zyprexa in the fourth quarter, allowing the company to beat analysts' expectations and raise its 2013 profit forecast.
Indiana lawmakers advance music therapist bill
A bill that would certify Indiana therapists who specialize in using music to treat people with autism, Alzheimer's and other conditions is advancing in the General Assembly.
Zimmer highly exposed to health-reform risk
Shares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company in its industry to two key elements of health care reform: the medical device tax and bundled payments.
Marian med school oversubscribed
Marian University’s College of Osteopathic Medicine—only the second medical school in Indiana—will enroll 162 students this fall, about 8 percent more than it planned.
Once-thriving drug lab in turnaround mode
Two years ago, executives at AIT Laboratories “took their eye off the ball,” and watched the company’s business plummet 29 percent in value. Now, after two years of turmoil, the drug-testing lab says it’s poised to return to the double-digit rates of growth that made it a local star.
WellPoint beats analysts’ estimates with 4th-quarter profit surge
The Indianapolis-based health insurer earned $464 million, or $1.51 per share, in the fourth quarter, a 38-percent leap from a year ago, and topped analysts’ forecasts by 8 cents per share.
Greenwood seeks funds back from drugmaker with big plans
Greenwood-based Elona Biotechnologies Inc., which has been trying to bring a generic version of insulin to market, was declared in default on $8.4 million in incentives from the city of Greenwood.
Q&A
Dave Reed is president of the Healthcare Business Solutions group inside Bloomington-based Cook Medical Inc. Since 2007, his team of 18 full-time people—aided by about 60 others throughout Cook’s organization—has worked with hospital systems, distributors of medical products and group purchasing organizations to improve the efficiency of the business side of health care and to make sure new products contribute to that efficiency, as well as solving unmet medical needs.
Pence wants $1.5M a year for life sciences institute
The Indiana Applied Research Enterprise already has received support from John Lechleiter, CEO of Indianapolis-based Eli Lilly and Co., as a place for collaboration between academic and industrial scientists.
Shepherd Insurance agency goes on buying spree
The Carmel insurance agency acquired three separate companies in a flurry of activity at the end of the year that will add 17 people to its staff.
Lilly drug chosen for Alzheimer’s prevention study
Researchers have chosen an experimental drug by Eli Lilly and Co. for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it.
Roche makes Fortune’s ‘Best Companies’ list
Roche Diagnostics Corp. in Indianapolis ranks 89th on the magazine’s latest “Best Companies to Work For” list and was the only Indiana-based company selected.